Which pharmaceutical company first implemented a Netflix-style subscription model for hepatitis C medications, allowing states to pay a flat fee for unlimited access to their treatments?

The healthcare industry has been exploring innovative payment models to make expensive treatments more accessible and predictable for both patients and healthcare systems. One groundbreaking approach involves subscription-based payment models for medications, particularly for high-cost treatments. This poll tests your knowledge about a pioneering subscription model that made headlines in the pharmaceutical industry.

This is a live public trivia poll on AIPolls.Net. Vote and see real-time results.

Gilead Sciences
AbbVie
Merck & Co.
Johnson & Johnson